Pharmaceutical Business | Investor Relations

Latest News

Upcoming audits at Kwality Pharmaceuticals in Q2 2024 includes INVIMA (Colombia), DIGEMID (Peru) and SFDA (Saudi Arabia)
Kwality Pharmaceutical manufacturing facilities are recently inspected by Botswana Medicines Regulatory Authority (BoMRA) from 11-16’th April 2024
Kwality Pharmaceutical Manufacturing Facility in Himachal Pradesh has been approved by ANVISA
Kwality develops it’s First Implant Injection : Goserelin Acetate Implant Injection

Home
- FOR ORDERS
  Ibm@kwalitypharma.com +91 9779177677
- FOR QUERY
  info@kwalitypharma.com +91 7657833389
- FOR JOBS
  hrd@kwalitypharma.com +91 9888014228

About
Facilities
Gallery
Investor Relations
Job Opportunities
Online Enquiry

TRADING WINDOW CLOSURE

Closure of Trading Window 31-03-2024
Closure of Trading Window 31-12-2023
Closure of Trading Window 30-09-2023
Closure of trading window 31-03-2023
closure of trading window 30-06-2022
Closure of trading window 31-03-22
CLOSURE OF TRADING WINDOW 01-04-2020
CLOSURE OF TRADING WINDOW 01-04-2021
CLOSURE OF TRADING WINDOW 01-04-2022
CLOSURE OF TRADING WINDOW 01-10-19
CLOSURE OF TRADING WINDOW 01-10-2021
CLOSURE OF TRADING WINDOW 14-11-17
CLOSURE OF TRADING WINDOW 14-11-18
CLOSURE OF TRADING WINDOW 16-11-19
CLOSURE OF TRADING WINDOW 16-11-19
CLOSURE OF TRADING WINDOW 20-05-17
CLOSURE OF TRADING WINDOW 22-05-19
CLOSURE OF TRADING WINDOW 29-06-2020
CLOSURE OF TRADING WINDOW 7-11-16

ABOUT KPL

USEFUL LINKS

Home
About
Facilities
Gallery
Annual Reports
Online Enquiry

Contacts

Ph.: +91-8558820861,62,63,64

Mail.: Info@kwalitypharma.com

Connect with us on Social

© Kwality Pharma LimitedAll Rights reserved. Design by Techies Infotech

Admin Login
Contact Us
Sitemap